Epidemiology of Hypertension

Hypertension: A Companion to Braunwald's Heart Disease: Second Edition

Volumn , Issue , 2013, Pages 1-11

  Lloyd Jones, Donald M ^a   Levy, Daniel ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84904233243     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-2766-1.00001-6     Document Type: Chapter

References (61)

1. Chobanian A.V., Bakris G.L., Black H.R., et al. Seventh Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003, 42:1206-1252.
2. Hill A.B. The environment and disease: association or causation?. Proc R Soc Med 1965, 58:295-300.
3. Hennekens C.H., Buring J.E. Epidemiology in Medicine 1987, Little, Brown, Boston.
4. Gillespie C., Kuklina E.V., Briss P.A., et al. Vital signs: prevalence, treatment, and control of hypertension: United States, 1999-2002 and 2005-2008. Morbidity & Mortality Weekly Report 2011, 60:103-108.
5. Roger V.L., Go A.S., Lloyd-Jones D.M., et al. Heart Disease and Stroke Statistics-2011 Update: a report from the American Heart Association. Circulation 2011, 123:e18-e209.
6. Burt V.L., Culter J.A., Higgins M., et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension 1995, 26:60-69.
7. Hajjar I., Kotchen T.A. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003, 290:199-206.
8. Heart Disease and Stroke Statistics - 2005 Update 2004, American Heart Association, Dallas, TX.
9. Yoon S., Otschega Y., Louis T. Recent Trends in the Prevalence of High Blood Pressure and Its Treatment and Control, 1999-2008 2010, National Center for Health Statistics, Hyattsville, MD.
10. Wolf-Maier K., Cooper R.S., Kramer H., et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004, 43:10-17.
11. Danaei G., Finucane M.M., Lin J.K., et al. National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5·4 million participants. Lancet 2011, 377:568-577.
12. Wolf-Maier K., Cooper R.S., Banegas J.R., et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003, 289:2363-2369.
13. Fields L.E., Burt V.L., Cutler J.A., et al. The burden of adult hypertension in the United States 1999 to 2000. A rising tide. Hypertension 2004, 44:398-404.
14. Vasan R.S., Beiser A., Seshadri S., et al. Residual lifetime risk for developing hypertension in middle-aged women and men: the Framingham Heart Study. JAMA 2002, 287:1003-1010.
15. Burt V.L., Whelton P., Roccella E.J., et al. Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995, 25:305-313.
16. Franklin S.S., Gustin W., Wong N.D., et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 1997, 96:308-315.
17. Lakatta E.G., Levy D. Arterial and cardiac aging: Major shareholders in cardiovascular disease enterprises. Part I. Aging arteries: A "set up" for vascular disease. Circulation 2003, 107:139-146.
18. Izzo J.L., Levy D., Black H.R. Importance of systolic blood pressure in older Americans. Hypertension 2000, 35:1021-1024.
19. Wang Y., Wang Q.J. The prevalence of prehypertension and hypertension among US adults according to the new Joint National Committee guidelines. Arch Intern Med 2004, 164:2126-2134.
20. Cutler J.A., Sorlie P.D., Wolz M., et al. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension 2008, 52:818-827.
21. Wilson P.W.F., D'Agostino R.B., Sullivan L., et al. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 2002, 162:1867-1872.
22. Lloyd-Jones D.M., Liu K., Colangelo L.A., et al. Consistently stable or decreased body mass index in young adulthood and longitudinal changes in metabolic syndrome components: the Coronary Artery Risk Development in Young Adults Study. Circulation 2007, 115:1004-1011.
23. Mamun A.A., Lawlor D.A., O'Callaghan M.J., et al. Effect of body mass index changes between ages 5 and 14 on blood pressure at age 14: findings from a birth cohort study. Hypertension 2005, 45:1083-1087.
24. Stamler J., Elliott P., Appel L., et al. Higher blood pressure in middle-aged American adults with less education-role of multiple dietary factors: the INTERMAP study. J Hum Hypertens 2003, 17:655-664.
25. Stamler J., Rose G., Elliott P., et al. Findings of the international cooperative INTERSALT study. Hypertension 1991, 17(suppl 1):I9-I15.
26. Levy D., DeStefano A.L., Larson M.G., et al. Evidence for a gene influencing blood pressure on chromosome 17: genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the Framingham Heart Study. Hypertension 2000, 36:477-483.
27. Newton-Cheh C., Johnson T., Gateva V., et al. Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet 2009, 41:666-676.
28. The Seventh Report of the Joint National Committee on Prevention Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 Report. JAMA 2003, 289:2560-2571.
29. Lloyd-Jones D.M., Evans J.C., Larson M.G., et al. Differential impact of systolic and diastolic blood pressure level on JNC-VI staging. Hypertension 1999, 34:381-385.
30. Pogue V.A., Ellis C., Michel J., Francis C.K. New staging system of the fifth Joint National Committee report on the detection, evaluation, and treatment of high blood pressure (JNC-V) alters assessment of the severity and treatment of hypertension. Hypertension 1996, 28:713-718.
31. Franklin S.S., Jacobs M.J., Wong N.D., et al. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives. Hypertension 2001, 37:869-874.
32. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002, 360:1903-1913. Prospective Studies Collaboration.
33. Wilson P.W., D'Agostino R.B., Levy D., et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97:1837-1847.
34. Levy D., Larson M.G., Vasan R.S., et al. The progression from hypertension to congestive heart failure. JAMA 1996, 275:1557-1562.
35. Dunlay S.M., Weston S.A., Jacobsen S.J., Roger V.L. Risk factors for heart failure: a population-based case-control study. Am J Med 2009, 122:1023-1028.
36. Kannel W.B., Gordon T., Schwartz M.J. Systolic versus diastolic blood pressure and risk of coronary heart disease: the Framingham study. Am J Cardiol 1971, 27:335-345.
37. Psaty B.M., Furberg C.D., Kuller L.H., et al. Association between blood pressure level and the risk of myocardial infarction, stroke, and total mortality. Arch Intern Med 2001, 161:1183-1192.
38. Neaton J.D., Wentworth D.N. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease: overall findings and differences by age for 316,099 white men. Arch Intern Med 1992, 152:56-64.
39. Neaton J.D., Kuller L., Stamler J., Wentworth D.N. Impact of systolic and diastolic blood pressure on cardiovascular mortality. Hypertension: Pathophysiology, Diagnosis, and Management 1995, 127-144. Raven Press, New York. 2nd ed. J.H. Laragh, B.M. Brenner (Eds.).
40. Franklin S.S., Khan S.A., Wong N.D., et al. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation 1999, 100:354-360.
41. Lloyd-Jones D.M., Evans J.C., Larson M.G., et al. Differential control of systolic and diastolic blood pressure: factors associated with lack of blood pressure control in the community. Hypertension 2000, 36:594-599.
42. Hyman D.J., Pavlik V.N. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med 2001, 345:479-486.
43. Somes G.W., Pahor M., Shorr R.I., et al. The role of diastolic blood pressure when treating isolated systolic hypertension. Arch Intern Med 1999, 159:2004-2009.
44. Lloyd-Jones D.M., Evans J.C., Larson M.G., Levy D. Treatment and control of hypertension in the community: a prospective analysis. Hypertension 2002, 40:640-646.
45. Stamler J., Stamler R., Neaton J.D. Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Arch Intern Med 1993, 153:598-615.
46. Vasan R.S., Larson M.G., Leip E.P., et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001, 345:1291-1297.
47. Vasan R.S., Larson M.G., Leip E.P., et al. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001, 358:1682-1686.
48. Chae C.U., Pfeffer M.A., Glynn R.J., et al. Increased pulse pressure and risk of heart failure in the elderly. JAMA 1999, 281:634-639.
49. Haider A.W., Larson M.G., Franklin S.S., Levy D. Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study. Ann Intern Med 2003, 138:10-16.
50. Mosley W.J., Greenland P., Garside D.B., Lloyd-Jones D.M. Predictive utility of pulse pressure and other blood pressure measures for cardiovascular outcomes. Hypertension 2007, 49:1256-1264.
51. USRDS 2011 Annual Data Report 2011, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (NIH), DHHS, Bethesda, MD.
52. Lloyd-Jones D.M., Leip E.P., Larson M.G., et al. Novel approach to examining first cardiovascular events after hypertension onset. Hypertension 2005, 45:39-45.
53. Lloyd-Jones D.M., Evans J.C., Larson M.G., et al. Cross-classification of JNC VI blood pressure stages and risk groups in the Framingham Heart Study. Arch Intern Med 1999, 159:2206-2212.
54. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation 2002, 106:3143-3421.
55. Meyer J. Age: 2000. Census 2000 brief 2001, U.S. Department of Commerce, Economics and Statistics Administration, U. S. Census Bureau, Washington, D.C.
56. Lloyd-Jones D.M., Evans J.C., Levy D. Hypertension in adults across the age spectrum: current outcomes and control in the community. JAMA 2005, 294:466-472.
57. Benjamin E.J., Levy D., Vaziri S.M., et al. Independent risk factors for atrial fibrillation in a population- based cohort. The Framingham Heart Study. JAMA 1994, 271:840-844.
58. Ho K.K., Pinsky J.L., Kannel W.B., Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993, 22(4 Suppl A):6A-13A.
59. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes Care 1988, 37:1595-1607.
60. Reaven G.M. Insulin resistance, hyperinsulinemia, and hypertriglyceridemia in the etiology and clinical course of hypertension. Am J Med 1991, 90(suppl 2A):7S-12S.
61. Kannel W.B., Wilson P.W., Silbershatz H., D'Agostino R.B. Epidemiology of risk factor clustering in elevated blood pressure. Multiple Risk Factors in Cardiovascular Disease 1998, 325-333. Kluwer Academic Publishers, New York. A.M. Gotto, C. L'Enfant, R. Paoletti (Eds.).